- Cellebrite Announces First-Quarter 2024 Results
- Cellebrite Announces Participation in Upcoming Investor Conferences
- Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024
- Cellebrite révolutionne la collecte de données avec une solution SaaS révolutionnaire faisant partie intégrante de la plateforme Case-to-Closure de l’entreprise
- Cellebrite revolutioniert die Datenerfassung mit bahnbrechender SaaS-Lösung als integralem Bestandteil der Case-to-Closure-Plattform des Unternehmens
- Cellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market Leadership
- Cellebrite Files its 2023 Annual Report on Form 20-F
- Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform
- UPDATE – Cellebrite Announces 2024 Investor Day
- Cellebrite Launches FedRAMP Authorization Process to Provide Federal Customers with Enhanced Cloud Security
More ▼
Key statistics
On Friday, Cellebrite DI Ltd (CLBT:NSQ) closed at 10.65, -14.80% below its 52-week high of 12.50, set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.56 |
---|---|
High | 10.75 |
Low | 10.42 |
Bid | 10.37 |
Offer | 11.14 |
Previous close | 10.52 |
Average volume | 1.26m |
---|---|
Shares outstanding | 205.30m |
Free float | 90.66m |
P/E (TTM) | -- |
Market cap | 2.19bn USD |
EPS (TTM) | -0.5781 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:15 BST.
More ▼